In Vivo - Citel...

ATMP Manufacturing: Complex Challenges Require Complex Solutions

Features

Inside Precisio...

The End of the Beginning for Cell and Gene Therapy, Part 2

Features

Chemical & Engi...

Turning tides for endotoxin testing

Features

Clinical Trials...

BIOSECURE Act: Companies turn to US manufacturers

Features

Scrip

BioCentriq CEO On Next Phase Of Growth With GC Support

Interview

BioPharm

Frontrunners in Automated Cell and Gene Therapy Manufacturing

Features

BioSpace

BioCentriq Appoints Syed T. Husain as Chief Executive Officer

Company Updates

Yahoo! Finance

BioCentriq Appoints Syed T. Husain as Chief Executive Officer

Company Updates

PharmTech

Frontrunners in Automated Cell and Gene Therapy Manufacturing

Features

The Medicine Ma...

How Advanced Therapy Manufacturing Can Be Augmented with Digital Transformation

Interview

Clinical Trials...

How will cell & gene therapy manufacturing look in 10 years?

Features

APM Health

‘Big hole’ for CDMOs in early cell and gene therapy space is adding to already soaring treatment costs – BioCentriq Executive

Interview